Streetbeat News

Earnings

LULU

Lululemon's stock is trading lower following the company's issuance of Q1 guidance that fell below estimates. Despite this, Barclays has maintained its Overweight rating on Lululemon but reduced its price target from $610 to $546.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 7:02 pm

LIDR

AEye (NASDAQ:LIDR) is scheduled to release its quarterly earnings report on March 26, 2024, with analysts expecting an EPS of $-1.20. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing share price drops the following day. AEye's stock has declined 82.14% over the last 52 weeks, trading at $1.65 as of March 22. Investors are looking for positive guidance for the next quarter beyond the earnings beat.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 7:01 pm

CCL

CRUZ

LUV

NCLH

RCL

Carnival Corp (NYSE:CCL) is set to report its Q1 earnings with anticipated revenue of $5.4 billion, a 22% increase from last year, and a reduced loss of $0.17 per share. Despite challenges in achieving profitability due to high costs and debt repayment, Carnival has seen record revenues and bookings. Rivals Royal Caribbean (NYSE:RCL) and Norwegian Cruise Line (NYSE:NCLH) also reported strong results, with shares of all three companies showing recent gains. The Defiance Hotel, Airline, and Cruise ETF (NYSE:CRUZ) gained 3.7% in 2024, despite the underperformance of airline stocks like Southwest Airlines (NYSE:LUV) due to issues with Boeing Co (NYSE:BA) jets.

Portfolio Pulse from Neil Dennis

March 25, 2024 | 6:06 pm

CMG

Financial analysis reveals a bearish trend in options trading for Chipotle Mexican Grill (NYSE:CMG), with 58% of trades showing bearish tendencies. The analysis highlighted unusual trades, with a focus on a price range target from $900 to $3750 for CMG over the last 3 months. Notable options activity includes both put and call trades with varying sentiments. Chipotle, the largest fast-casual chain in the U.S., reported systemwide sales of $9.9 billion in 2023. The stock is slightly up by 0.21% at $2888.0, with potential overbought indications. Analyst ratings from Wedbush and Deutsche Bank offer mixed views, with target prices of $2850 and $3300, respectively.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 6:01 pm

FRGE

Forge Global Holdings (NYSE:FRGE) is scheduled to report its quarterly earnings on 2024-03-26, with analysts expecting an EPS of $-0.10. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss leading to a 0.43% drop. Shares have risen 69.26% over the last 52 weeks, indicating a positive long-term outlook. Investors will be keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 6:00 pm

GDRX

Wells Fargo upgraded GoodRx Holdings Inc (NASDAQ:GDRX) from Equal Weight to Overweight with a new price target of $10, citing good visibility into 2024 guidance and potential for exceeding estimates and valuation multiples by 2025. GoodRx's strategic initiatives and partnerships are expected to improve revenue visibility and reduce downside risks, with recent data showing an increase in web traffic compared to its competitor, SingleCare. The company's fourth-quarter FY23 results and FY24 revenue guidance were above estimates, indicating a strong performance outlook.

Portfolio Pulse from Vandana Singh

March 25, 2024 | 6:00 pm

AAPL

AMD

GOOGL

INTC

META

XLE

US stocks saw a mixed session with tech giants like Apple, Alphabet, and Meta facing regulatory scrutiny, while energy stocks surged due to rising crude prices. The Energy Select Sector SPDR Fund reached levels close to its all-time highs. Intel and AMD stocks were volatile after China's move to phase out U.S. microprocessors. Bitcoin reclaimed $70,000. Notable stock movements included gains for Bitcoin-related companies and Micron Technology, while United Airlines and Take-Two Interactive faced declines.

Portfolio Pulse from Piero Cingari

March 25, 2024 | 5:58 pm

JNJ

Biosense Webster, a Johnson & Johnson MedTech company, has submitted the VARIPULSE™ Platform for FDA approval for treating Paroxysmal Atrial Fibrillation. Supported by the admIRE study, the platform includes a catheter, generator, and software integrated with the CARTO™ 3 System for real-time cardiac mapping. The study showed 100% acute success and 80% freedom from atrial arrhythmia recurrence at 12 months, with no reported adverse events.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 5:49 pm

WHR

Investors have shown a bearish stance on Whirlpool (NYSE:WHR), with options activity indicating a split sentiment of 36% bullish and 63% bearish. Benzinga's options scanner revealed 11 significant trades, focusing on a price band between $95.0 and $125.0. The trading volume and open interest trends suggest a keen market interest in WHR's options. Whirlpool's current stock position is at $111.18, with an upcoming earnings announcement in 28 days.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 5:45 pm

CYTO

LABP

MEDS

NKTX

SGMT

XTLB

Health care stocks experienced significant movements in Monday's intraday session. Landos Biopharma's shares surged by 173.9% following their Q4 earnings report. Other notable gainers include Altamira Therapeutics, XTL Biopharmaceuticals, Nkarta, Sagimet Biosciences, and Molecular Templates. On the downside, Trxade Health led the losers with a 48.6% drop, followed by declines in SINTX Techs, Akanda, Invivyd, 180 Life Sciences, and Kineta.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 5:31 pm